New York, NY Thor Equities, a global leader in urban real estate development, leasing and management, has launched Thor Sciences, a division specializing in the life sciences sector.
This comes on the heels of Thor’s $152 million acquisition of The Center of Excellence, a 784,000 s/f campus that spans 48 acres located in Bridgewater, NJ. Comprised of laboratory, research and development, and office buildings, the complex features life science companies specializing in pharmaceuticals and health services.
including anchor tenants Nestlé Health Science, Ashland, and Amneal Pharmaceuticals. Additional tenants include Insmed, Avantor, Nevakar, Solaris Pharma, Clinical Genomics, Matinas BioPharma, Vertice Pharma, 3D Biotek, Unionmed Tech and GSG Scientific. Expansion plans for The Center of Excellence are expected to be in excess of tens of millions of dollars.
A key player in The Center of Excellence acquisition, and unveiling of Thor’s global platform, is Bill Hunter, SVP of Thor Sciences. Bill is an accomplished professional with over twenty years of experience who is nationally recognized as an expert in the life science and higher-education verticals. He has executed $4 billion in acquisitions, consisting of 7.5 million rentable s/f and 3 million s/f of strategic campus re-positioning projects for major life science and university campus developments in scientific clusters covering the U.S. coastlines from Boston to Miami and San Francisco to San Diego.
“We are pleased to announce the launch of Thor Sciences as well as the acquisition of The Center of Excellence,” said Thor’s chairman and CEO, Joseph Sitt. “We have been an early advocate for the sector, having previously acquired assets in Berkeley and Boston, and are now ready to advance our global platform with the appointment of Life Sciences expert and new Senior Vice President, Bill Hunter. Bringing over twenty years of experience to Thor, Bill played an instrumental role in the acquisition of our new aforementioned trophy asset and we are thrilled to welcome him to the Thor team. The Life Sciences sector has gained unbelievable traction in recent years,” said Bill Hunter. “The chance to work with Joe and the Thor team presents an exciting opportunity as we launch Thor Sciences. With Thor’s strong knowledge base across all asset classes, this new division knows no bounds. Alongside Thor’s team of experts, I look forward to creating a world-class property, and contributing to the acquisition and development of properties throughout the U.S. and beyond and becoming the leading authority in the life sciences industry."